ArticleBMC public health2026
Structural barriers drive the intention-action gap in hepatitis B prevention among migrants in Shandong Province, China: a triangulated study of serological, spatial, and behavioral data.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHepatitis B virus (HBV) infection remains a major public health challenge in China. Migrant workers constitute a highly vulnerable population due to high geographic mobility and occupational vulnerability. Despite public health education efforts, a notable intention-action gap disrupts the HBV care cascade. This study integrates serological, spatial, and behavioral data to investigate whether this gap is primarily driven by cognitive deficits or interrupted by underlying structural barriers.
methodsA triangulated cross-sectional study was conducted in Yantai, China, involving structured questionnaire surveys (N = 1,184) and serological testing (N = 2,364). The spatial distribution of regional anti-HBs positive rates was mapped using Geographic Information Systems (GIS). An adapted Health Belief Model was tested using Structural Equation Modeling (SEM) with a Robust Maximum Likelihood estimator to evaluate the disruptive effects of objective structural constraints-specifically, time poverty, economic constraints, and systemic lack of medical insurance.
resultsThe serologically confirmed anti-HBs positive rate was 51.10% (1,208/2,364), substantially lower than the 70% threshold recommended by the World Health Organization. Spatial analysis revealed significant geographic heterogeneity (χ² = 74.38, P < 0.001), with higher immunity concentrated in large-scale industrial belts (67.33%) and lower immunity clustered in dispersed service-sector districts (36.81%). SEM results indicated that while external cues strongly predicted HBV knowledge (β = 0.894), knowledge had only a marginal effect on preventive intention (β = 0.192). Preventive intention significantly predicted actual behavior (β = 0.655). However, this motivational process was severely undermined by structural barriers, predominantly time poverty (β = -0.563, P < 0.001), followed by economic constraints (β = -0.278, P < 0.001) and lack of medical insurance (β = -0.056, P = 0.030).
conclusionsThe intention-action gap in HBV prevention among migrant workers is primarily driven by socioeconomic structural barriers-most notably time poverty-while basic HBV knowledge remains a foundational but insufficient condition for preventive action. Achieving the goal of viral hepatitis elimination requires a shift from individual cognitive persuasion to structural interventions, emphasizing workplace-based service delivery, spatially targeted resource allocation, and insurance reforms to alleviate out-of-pocket and opportunity costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.